A growing list of companies are exiting the public market to shield themselves from growing regulatory and investor pressure to lift valuations and implement more oversight.
CEO of Salonpas maker seeks to take $2.9 billion drug firm private
Published 1 day ago
Source: japantimes.co.jp
Categories
BUSINESS
Related Articles from japantimes.co.jp
8 hours ago
Former Fukui governor’s actions could be seen as sexual assault, lawyers say
8 hours ago
China's dual-use export ban on Japan a decisive escalation
8 hours ago
Hisamitsu shares jump most since 1978 on $2.9 billion buyout
9 hours ago
An affectionate Akita named Araki
10 hours ago
Japan stops Chubu Electric's nuclear review due to flawed seismic data
10 hours ago